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Introduction 
Previous evaluation of mouthwashes, have very largely concentrated on 
determinations on the anti-plaque activity (Axelsson, 1987), their 
ability to control gingivitis, (Clark et aI, 1987) and the effects of specific 
chemical agents used to reduce the bacterial count (Hogg, 1987). A 
pharmaceutical and microbiological analysis of 14 mouthwashes 
available in Malta were investigated, at St Luke's Hospital and the 
University of Malta. 
Methodology 
Three studies were carried out over a 30 week period. 
Studyl 
A pharmaceutical and stability analysis on Compound Thymol 
mouthwash, an extemporaneous product prepared at the Government 
Medical Stores was investigated in an attempt to solve the 
crystallization and precipitation that formed. This was assessed as 
follows: 
1. Crystals were separated, purified and identified by physical and 
chemical methods . 
• 2. The formulation of the product was slightly amended in order to 
improve the product from a pharmaceu tical and chemical 
approach. 
3. A stability study on the modified product was performed. 
Study 2 
A. This study was developed on a method performed by Richards R. 
et al (1989) and was then compared with the results achieved in Malta. 
Furthermore this study was reported with additional data. 
The reproducibility of a standardised rinse/gargle procedure (itemised 
below) was investigated by determining the aerobic bacterial count of 3 
consecutive rinse/gargle routines following steps 1,2 and 3 below using 5 
subjects. Colony counts were performed on each of the samples by diluting 
appropriately in sterile water, spreading 0.1 ml on overdried blood agar 
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plates and incubating at 37°C for 48 hours. The standard deviation was 
calculated to check if the method could form the basis of an in vivo 
evaluation of mouthwashes on the bacterial flora of the mouth and 
throat. The standardised rinse/gargle procedure was as follows: 
1. Take 15ml sterile deionised water in the mouth for a 30 second 
mouthwash by the following method: 
(a) For 10 secs - gargle to back of throat; (b) For 10 sec - using 
tongue, wash teeth, gums and checks mechanically; (c) For 10 secs -
rinse mouth. 
2. Expectorate the solution into a sterile container. 
3. Wait one minute. 
4. (a) Repeat step 1 using 15ml of proprietary mouthwash provided; 
(b) Expectorate the solution into the container provided containing 
15ml of inactivator solution (3% Tween 80, 0.5% l~cithin in 
thlOglycollate broth USP); (c) Wait one minute. 
5. Repeat steps 1 and 2 using the second 15ml volume of sterile 
deionised water. 
6. Return in 60 minutes (during which nothing should be consumed and 
repeat steps 1 and 2 using a third 15ml volume of sterile deionised 
water provided. 
B. The standarised rinse gargle procedure above was followed by 6 
subjects randomly selected from the local hospital staff to evaluate each 
of 14 mouthwashes. Inactivated mouthwashes were plated to obtain 
colony counts as before. 
C. One mouthwash with poor and another with good antibacterial 
activity selected from the previous study were subjected to 3 physical 
parametel,'s (time, temperature and volume) to investigate if the 
bacterial count was further reduced. 
Study 3 
100 people were interviewed (62 females; 38 males) to investigate the 
public's knowledge and practices concerning mouthwashes. In addition 
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they were asked about the criteria of their choice of mouthwashes, who 
recommended the mouthwash and if they were aware of adverse effects 
that these products could possibly impart. 
Results 
Studyl 
This pharmaceutical investigation showed that the hospital' used a 
preparation that was several times amended by "The Extra 
Pharmacopoeia". In addition products in the formulation that had 
expired were still being used. Preparing the product with freshly 
compounded products still gave crystallisation on standing and on 
identification the crystals were found to be benzoic acid. This solubility 
problem was solved with the addition of more alcohol to the formulation 
and the reduction of water. With the new amendments made to the 
formulation the expiry date was 2 weeks which was rather short. Cooper 
and Gunn (1975)states that most extemporaneous solutions have a shelf 
life of approximately 1 month. The product could only be dispensed with 
the condition that it was to be discarded after 10 days. As the product 
used to be prepared in bulk, it would no longer be possible for the hospi tal 
to prepare it as it would be economically unfeasible. 
Study 2 
The reproducibility procedure gave results which were satisfactory when 
compared with the U.K. in that they were fairly reproducible. The 
method employed indicates that it can form the basis of an "In-vivo" 
evaluation of the effects of mouthwashes on the aerobic bacterial flora of 
the mouth and throat. Figure 1 below are the comparative results. 
The results of the mouthwash effectiveness is represented in Figure 2. 
This represents the pooled results for 6 subjects used to evaluate each of 
the 14 mouthwashes. The most effective mouthwashes had low numbers 
of viable organisms in the actual mouthwash rinse when compared with 
the initial number present in the pre-test evaluation. Furthermore, the 
sterile water used to rinse the mouth and throat one minute after using 
the effective mouthwash also contained comparatively low numbers of 
organisms. This represents a >99.5% reducation in colony forming units 
(C.F.U.) after one minute after the following mouthwashes were used: 
OraldeneR, BetadineR, CorsodylR, BocasanR and ListermintR. As for 
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Subject 
1 
2 
3 
4 
5 
United Kingdom 
Average Standard 
Count Deviation 
x 106ml 
4.2 0.3 
0.2 0.1 
6.7 0.3 
0.8 0.6 
3.4 0.8 
Malta 
Average Standard 
Count Deviation 
x 106ml 
0.6 0.1 
0.5 0.2 
0.7 0.1 
0.7 0.2 
0.6 0.2 
Figure 1. The results show the average count and the standard deviation 
(S.D.) of the aerobic bacterial flora of the mouth. The greater 
the variations of the (S.D.), the less valid of the test. 
ListerineR, DettolR, Acti-brushR, ReachR, AntoralR, Compount Thymol 
Glycerine, Saline, Hydrogen peroxide and Potassium permanganate the 
percentage reductions in C.F.U. were 83%, 30%,96%, 92%, 86%, 37%, 84% 
and 41 % respectively. After one hour the results for all products 
expressed as the percentage reductions in C.F.U. were CorsodylR 93%, 
Oraldene R 92%, BetadineR 92%, BocasanR 89%, ListerineR 31 %, 
ListermintR 80%, DettolR 3%, Acti-brushR 81 %, ReachR 87%, AntoralR 
75%, Compound Thymol Glycerine 72%, Saline 11 %, Hydrogen peroxide 
29% and Potassium permanganate 26%. 
From the above mouthwashes, only six were similarly studied in the 
U.K. as the others are either non-proprietary mouthwashes or are recent 
products that were on the market since two years ago. The comparative 
results below, show that they are closely correlated (CorsodyIR: Malta 
93%; U.K. 89%); (OraldeneR: Malta 92%; U.K. 91%); (BetadineR: 
Malta 92%; U.K. 91 %); (BocasanR: Malta 89%; u.K. 88%); (ListerineR: 
Malta 29%; U.K. 22%); (DettoIR: Malta 3%; U.K. 0%). 
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Mouthwash Percentage Effectiveness 
Mouthwash After 1 min. After 1 hr 
- Corsodyl 99.5 93.0 
- Oraldene 99.5 92.0 
- Betadene 99.5 92.0 
- Bocasan 99.5 89.0 
- Listerine 83.0 31.0 
- Listermint 99.5 80.0 
- Dettol 30.0 3.0 
- Acti-brush 96.0 81.0 
- Reach 92.0 87.0 
- Antoral 86.0 75.0 
- Saline 37.0 11.0 
- Hydrogen peroxide 84.0 29.0 
- Permanganate 41.0 26.0 
- Compound Thymol 86.0 72.0 
Glycerine 
FigUI'e 2. The results show the percentage effectiveness of the 14 
mouthwashes analysed. Each mouthwash was analysed by 6 
subjects and the average percentage count was calculated. 
Listermint and Listerine were the selected mouthwashes from the 
previous study. These were exposed to the following physical 
proportions: The volume, time and temperature from 15mls, 30 secs and 
25°C were increased to 50mls, 4 mins and 45°C. The following 
observations were made: For Volume there was a 5.7%, for temperature 
there was a 10.4% and for time there was an 8% further reduction in the 
bacterial count frpm .the original 80% for ListermintR. For ListerineR it 
was 5.8%, 7/78% and 3.44% respectively from the original 30% of the 
bacterial count. 
Study 3 
100% of the patients (n=100) responded to the questionnaire. 30% used a 
mouthwash of which 20% (n=30) use a particular brand. 20% (n=lOO) 
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had a mouthwash prescribed by a dentist and pharmacists or doctors do 
not prescribe such products. 50% (n=l00) knew the difference between a 
gargle and a mouthwash while 90% (n=100) knew that such products 
contained some form of medication. Only 30% (n=100) knew that such 
products imparted side-effects if over used. 10% (n= 1 00) bought 
mouthwashes to treat halitosis (bad breath) or to treat stomatitis, 80% 
(n=100) to treat ulcers or dental caries while 40% use them to keep their 
mouth clean. 70% (n=100) consider price, flouride content and 
manufacturer's claims as the criteria for their choice of buying a 
mouthwash while 40% (n=100) consider taste as well. All people 
questioned (n=100) agreed that more health education is required 
concerning these products. 
Discussion and Conclusion 
To achieve the acquired standards of oral health it is necessary for a 
pharmacist as an educator to know what a truly effective mouthwash is. 
Both pharmaceutical and antibacterial properties, should be taken into 
consideration. 
The pharmaceutical analysis showed that mouthwashes must be 
correctly prepared, stored and periodically tested by some forms of 
quality control. Such procedures ensure that it reaches the patient safely 
and offers its full activity when used. Suggestions to substitute Compound 
Thymol mouthwash to Compound Thymol Glycerine was recommended as 
this product has a recognised B.P. standard assay so that it could be 
routinely analysed. 
The microbiological analysis gave an idea about the antibacterial 
effectiveness and what physical conditions exposed to these 
mouthwashes would further their activity. 
The survey indicates that the public requires oral health eduction 
concerning mouthwashes. In addition dispensing the correct mouthwash 
and giving the necessary advice for use in combination with 
toothbrushing procedures will help to promote high standards of oral 
health. The pharmacist is the likely candidate to bring this into action. 
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